Search

everythinglearnresearchcommunity

for

Search:↓

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Long-term use of pyrithione zinc shampoos remains effective for scalp seborrheic dermatitis, with decreased effectiveness likely due to not following treatment instructions rather than the treatment itself.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

Key proteins and pathways regulate yak hair growth, with lipid metabolism aiding adaptation to high altitudes.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

Tazarotene gel is more effective for acne than tretinoin and works as well as adapalene.

XMU-MP-1 stops cell growth in a human mini-organ and reduces the effectiveness of the chemotherapy drug paclitaxel.

THAP1 gene changes do not affect DYT1 dystonia; finasteride may help reduce tics and OCD in Tourette syndrome.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

AZD6244 treatment causes skin aging effects by depleting skin stem cells.

A patient with zinc depletion improved after zinc supplementation during parenteral nutrition.

Targeted protein degraders show promise in treating cancer but need to target more diverse proteins.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

Deucravacitinib led to full hair regrowth in a severe alopecia areata patient.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Pazopanib treatment caused rapid hair color loss, possibly indicating its effectiveness.

An intact skin barrier is crucial to prevent infection in cases of tether-induced tenosynovitis.

CTP-543 is generally safe for treating alopecia areata.

TAF4 is important for skin cell growth and helps prevent skin cancer in mice.

A woman's sudden hair loss was linked to azathioprine use despite normal enzyme levels, and improved after stopping the drug and starting treatment.

TAK-279 effectively reduces psoriasis symptoms and is safe.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

YH0618 helped reduce skin and nail problems and fatigue in chemotherapy patients.

Tofacitinib may help regrow hair in alopecia areata patients.

Cyclosporin A vesicles effectively regrow hair and reduce inflammation in alopecia areata.